Related content

Allogeneic Tumor Vaccine Produced by Electrofusion between Osteosarcoma Cell Line and Dendritic Cells in the Induction of Antitumor Immunity

By Yu Zhe   Ma Bao'an   Zhou Yong   Zhang Minghua   Long Hua   Wang Yucai   Fan Qingyu  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 535-541

Informa Healthcare

Access to resources Recommend Favorite

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma

By Yasuda Takashi   Kamigaki Takashi   Kawasaki Kentaro   Nakamura Tetsu   Yamamoto Masashi   Kanemitsu Kiyonori   Takase Shiro   Kuroda Daisuke   Kim Yongsik   Ajiki Tetsuo   Kuroda Yoshikazu  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1025-1036

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

By Ou Xueling   Cai Shaohui   Liu Peng   Zeng Jun   He Yuwen   Wu Xinyao   Du Jun  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 525-533

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell–tumor cell hybrid vaccination for metastatic cancer

By Barbuto Jose   Ensina Luis   Neves Andreia   Bergami-Santos Patrícia   Leite Katia   Marques Ricardo   Costa Frederico   Martins Siderleny   Camara-Lopes Luiz   Buzaid Antonio  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1111-1118

Springer Publishing Company

Access to resources Recommend Favorite

Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine

By                

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1799-1803

Spandidos Publications

Access to resources Recommend Favorite